A detailed history of Dcf Advisers, LLC transactions in Lensar, Inc. stock. As of the latest transaction made, Dcf Advisers, LLC holds 240,600 shares of LNSR stock, worth $1.84 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
240,600
Previous 241,484 0.37%
Holding current value
$1.84 Million
Previous $1.09 Million 1.38%
% of portfolio
0.46%
Previous 0.59%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.99 - $5.44 $3,527 - $4,808
-884 Reduced 0.37%
240,600 $1.1 Million
Q2 2024

Aug 12, 2024

BUY
$3.0 - $4.88 $9,750 - $15,860
3,250 Added 1.36%
241,484 $1.09 Million
Q1 2024

May 15, 2024

SELL
$3.25 - $5.0 $7,475 - $11,500
-2,300 Reduced 0.96%
238,234 $809,000
Q4 2023

Feb 13, 2024

SELL
$2.01 - $3.51 $84,424 - $147,427
-42,002 Reduced 14.87%
240,534 $844,000
Q3 2023

Nov 13, 2023

SELL
$3.02 - $4.45 $21,979 - $32,387
-7,278 Reduced 2.51%
282,536 $873,000
Q2 2023

Aug 09, 2023

SELL
$2.3 - $4.34 $140,134 - $264,427
-60,928 Reduced 17.37%
289,814 $1.23 Million
Q1 2023

May 15, 2023

BUY
$2.19 - $3.27 $10,950 - $16,350
5,000 Added 1.45%
350,742 $873,000
Q4 2022

Feb 13, 2023

SELL
$2.7 - $5.9 $33,358 - $72,894
-12,355 Reduced 3.45%
345,742 $1.02 Million
Q3 2022

Nov 14, 2022

BUY
$4.94 - $7.0 $304,175 - $431,018
61,574 Added 20.77%
358,097 $1.99 Million
Q2 2022

Aug 11, 2022

BUY
$6.15 - $7.94 $58,425 - $75,430
9,500 Added 3.31%
296,523 $1.93 Million
Q1 2022

May 13, 2022

BUY
$5.8 - $8.2 $41,963 - $59,326
7,235 Added 2.59%
287,023 $2.12 Million
Q2 2021

Aug 13, 2021

BUY
$6.87 - $8.66 $188,670 - $237,829
27,463 Added 10.88%
279,788 $2.42 Million
Q1 2021

May 12, 2021

BUY
$6.28 - $9.56 $597,071 - $908,917
95,075 Added 60.46%
252,325 $1.83 Million
Q4 2020

Feb 12, 2021

BUY
$6.7 - $12.2 $1.05 Million - $1.92 Million
157,250 New
157,250 $1.14 Million

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $84.4M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Dcf Advisers, LLC Portfolio

Follow Dcf Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.